Thor Medical - Grant of restricted stock units (RSU) to the members of the board

02 May 2025 19:55 CEST

2.5.2025 19:55:48 CEST | Thor Medical ASA | Additional regulated information
required to be disclosed under the laws of a member state

Oslo, Norway, 2 May 2025

Reference is made to the stock exchange announcement made by Thor Medical ASA
(the "Company") the Company on 24 April 2025 whereby it was disclosed that the
Company's annual meeting resolved ("AGM"), among other things, the approval of a
restricted share units ("RSU") program.

At the AGM, the shareholders approved the remuneration to the Company's current
board of directors whereby the board members were given the choice to receive
their remuneration, or a part thereof, for the period from the AGM to the annual
general meeting of 2026, in the form of restricted share units ("RSU"), as a
part of the Company's RSU program. The allocation of RSUs has today been made.

The number of RSUs allocated to each board member has been determined based on
the NOK value for the RSU-selected portion of the total compensation for the
board member. The compensation is divided by the subscription price of NOK
2.4295, equal to the 10-day volume weighted average prior the general meeting. A
total of 274,401 RSUs has been allocated to the following board members:

* Mimi Kristine Berdal: 54,880 RSUs
* Thomas Ramdahl: 54,880 RSUs
* Jens Gisle Schnelle: 164,641 RSUs

Primary insider notifications pursuant to the market abuse regulation article 19
are attached. This information is required to be disclosed under Section 5-12 of
the Securities Trading Act.

CONTACTS

Brede Ellingsæter, CFO & COO, Thor Medical ASA, +47 472 38 440,
brede.ellingseter@thormedical.com

ABOUT THOR MEDICAL ASA

Thor Medical is an emerging supplier of radionuclides, primarily alpha particle
emitters, from naturally occurring thorium. Its proprietary production process
requires no irradiation or use of nuclear reactors, and provides reliable,
environmentally friendly, cost-efficient supply of alpha-emitters for the
radiopharmaceutical industry. Thor Medical is headquartered in Oslo, Norway and
listed on the Oslo Stock Exchange under the ticker symbol 'TRMED'.

To learn more, visitwww.thormedical.no - http://visitwww.thormedical.no -
https://www.thormedical.no.

ATTACHMENTS

Download announcement as PDF.pdf -
https://kommunikasjon.ntb.no/ir-files/17848634/18514604/6040/Download%20announce
ment%20as%20PDF.pdf

More information:
Access the news on Oslo Bors NewsWeb site

645209_Download announcement as PDF.pdf